» Authors » Marc Combalia

Marc Combalia

Explore the profile of Marc Combalia including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 290
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Giavedoni P, Romani J, de Cabo F, Garcia-Martinez F, Quintana-Codina M, Roe-Crespo E, et al.
Diagnostics (Basel) . 2025 Mar; 15(5). PMID: 40075816
There have been multiple studies on the use of Doppler ultrasound to define skin inflammation, but the visible vessels of healthy skin have yet to be described. This study aimed...
2.
Kurtansky N, Primiero C, Betz-Stablein B, Combalia M, Guitera P, Halpern A, et al.
J Eur Acad Dermatol Venereol . 2024 Dec; PMID: 39648687
Background: While the high accuracy of reported AI tools for melanoma detection is promising, the lack of holistic consideration of the patient is often criticized. Along with medical history, a...
3.
Hernandez-Perez C, Combalia M, Podlipnik S, Codella N, Rotemberg V, Halpern A, et al.
Sci Data . 2024 Jun; 11(1):641. PMID: 38886204
Advancements in dermatological artificial intelligence research require high-quality and comprehensive datasets that mirror real-world clinical scenarios. We introduce a collection of 18,946 dermoscopic images spanning from 2010 to 2016, collated...
4.
Sangers T, Kittler H, Blum A, Braun R, Barata C, Cartocci A, et al.
J Eur Acad Dermatol Venereol . 2023 Sep; 38(1):22-30. PMID: 37766502
Background: As the use of smartphones continues to surge globally, mobile applications (apps) have become a powerful tool for healthcare engagement. Prominent among these are dermatology apps powered by Artificial...
5.
Liopyris K, Navarrete-Dechent C, Marchetti M, Rotemberg V, Apalla Z, Argenziano G, et al.
J Invest Dermatol . 2023 Sep; 144(3):531-539.e13. PMID: 37689267
Dermoscopy aids in melanoma detection; however, agreement on dermoscopic features, including those of high clinical relevance, remains poor. In this study, we attempted to evaluate agreement among experts on exemplar...
6.
Vinke P, Combalia M, de Bock G, Leyrat C, Spanjaart A, Dalle S, et al.
BMJ Open . 2023 Apr; 13(4):e069090. PMID: 37105689
Introduction: Immunotherapies, such as immune checkpoint inhibitors and chimeric antigen receptor T-cell therapy, have significantly improved the clinical outcomes of various malignancies. However, they also cause immune-related adverse events (irAEs)...
7.
Alamon-Reig F, Combalia M, Albero-Gonzalez R, Alos L, Carrera C, Puig-Butille J, et al.
J Eur Acad Dermatol Venereol . 2023 Jan; 37(5):914-921. PMID: 36695073
Background: Blue nevi are benign dermal melanocytic proliferations that are often easy to recognize clinically. Rarely, these lesions can display atypical features, suggesting the presence of a malignant blue nevus...
8.
Calbet-Llopart N, Combalia M, Kiroglu A, Potrony M, Tell-Marti G, Combalia A, et al.
Br J Dermatol . 2022 Jun; 187(5):753-764. PMID: 35701387
Background: Hypomorphic MC1R variants are the most prevalent genetic determinants of melanoma risk in the white population. However, the genetic background of patients with wildtype (WT) MC1R melanoma is poorly...
9.
Celebi M, Barata C, Halpern A, Tschandl P, Combalia M, Liu Y
Med Image Anal . 2022 May; 79:102468. PMID: 35537339
No abstract available.
10.
Combalia M, Codella N, Rotemberg V, Carrera C, Dusza S, Gutman D, et al.
Lancet Digit Health . 2022 Apr; 4(5):e330-e339. PMID: 35461690
Background: Previous studies of artificial intelligence (AI) applied to dermatology have shown AI to have higher diagnostic classification accuracy than expert dermatologists; however, these studies did not adequately assess clinically...